Home LiteratureArticle Details
PMID: 21901837 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Dystrophic serotonin axons in postmortem brains from young autism patients.

Anatomical record (Hoboken, N.J. : 2007) ·Vol. 294 ·No. 10 ·2011-10-00 ·Pages 1653-62

Azmitia EC, Singh JS, Hou XP, Wegiel J

Abstract

Autism causes neuropathological changes in varied anatomical loci. A coherent neural mechanism to explain the spectrum of autistic symptomatology has not been proposed because most anatomical researchers focus on point-to-point functional neural systems (e.g., auditory and social networks) rather than considering global chemical neural systems. Serotonergic neurons have a global innervation pattern. Disorders Research Program, AS073234, Program Project (JW). Their cell bodies are found in the midbrain but they project their axons throughout the neural axis beginning in the fetal brain. This global system is implicated in autism by animal models and by biochemical, imaging, pharmacological, and genetics studies. However, no anatomical studies of the 5-HT innervation of autistic donors have been reported. Our review presents immunocytochemical evidence of an increase in 5-HT axons in postmortem brain tissue from autism donors aged 2.8-29 years relative to controls. This increase is observed in the principle ascending fiber bundles of the medial and lateral forebrain bundles, and in the innervation density of the amygdala and the piriform, superior temporal, and parahippocampal cortices. In autistic donors 8 years of age and up, several types of dystrophic 5-HT axons were seen in the termination fields. One class of these dystrophic axons, the thick heavily stained axons, was not seen in the brains of patients with neurodegenerative diseases. These findings provide morphological evidence for the involvement of serotonin neurons in the early etiology of autism, and suggest new therapies may be effective to blunt serotonin's trophic actions during early brain development in children.

MeSH Terms
Adolescent Adult Autistic Disorder/metabolism,pathology Brain/metabolism,pathology Child Child, Preschool Humans Neuroaxonal Dystrophies/metabolism,pathology Neurodegenerative Diseases/metabolism,pathology Serotonin/metabolism Young Adult
Chemicals
Serotonin
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Azmitia Efrain C
Department of Biology, New York University, New York, 10003, USA. eca1@nyu.edu
Singh Jorawer S
Hou Xiao P
Wegiel Jerzy
References (107)
107 references, click to expand
  1. Cortical serotonin type-2 receptor density in parents of children with autism spectrum disorders.
    J Autism Dev Disord. 2009 Jan;39(1):97-104 PMID: 18592367
  2. Effects of tryptophan depletion in drug-free adults with autistic disorder.
    Arch Gen Psychiatry. 1996 Nov;53(11):993-1000 PMID: 8911222
  3. Transient microcircuits formed by subplate neurons and their role in functional development of thalamocortical connections.
    Neuroreport. 2004 Oct 5;15(14):2149-53 PMID: 15371723
  4. Localized decrease in serotonin transporter-immunoreactive axons in the prefrontal cortex of depressed subjects committing suicide.
    Neuroscience. 2002;114(3):807-15 PMID: 12220580
  5. Anatomical distribution of serotonin-containing neurons and axons in the central nervous system of the cat.
    J Comp Neurol. 2001 Apr 30;433(2):157-82 PMID: 11283957
  6. The distribution of structural neuropathology in pre-clinical Huntington's disease.
    Brain. 2002 Aug;125(Pt 8):1815-28 PMID: 12135972
  7. Autism in fetal alcohol syndrome: a report of six cases.
    Alcohol Clin Exp Res. 1992 Jun;16(3):558-65 PMID: 1626656
  8. Relationship between whole blood serotonin and repetitive behaviors in autism.
    Psychiatry Res. 2010 Feb 28;175(3):274-6 PMID: 20044143
  9. Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans.
    J Clin Invest. 2008 Apr;118(4):1544-52 PMID: 18317590
  10. [123I]beta-CIT SPECT demonstrates decreased brain dopamine and serotonin transporter levels in untreated parkinsonian patients.
    Mov Disord. 2001 Jan;16(1):124-30 PMID: 11215571
  11. Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia.
    Biol Psychiatry. 2007 Oct 1;62(7):711-21 PMID: 17568569
  12. A clinicopathological study of autism.
    Brain. 1998 May;121 ( Pt 5):889-905 PMID: 9619192
  13. Behavioral and cellular consequences of increasing serotonergic activity during brain development: a role in autism?
    Int J Dev Neurosci. 2005 Feb;23(1):75-83 PMID: 15730889
  14. Neurons in the fusiform gyrus are fewer and smaller in autism.
    Brain. 2008 Apr;131(Pt 4):987-99 PMID: 18332073
  15. Moderate alcohol exposure compromises neural tube midline development in prenatal brain.
    Brain Res Dev Brain Res. 2003 Aug 12;144(1):43-55 PMID: 12888216
  16. Neurochemical correlates of autistic disorder: a review of the literature.
    Res Dev Disabil. 2006 May-Jun;27(3):254-89 PMID: 16002261
  17. Neurobiological mechanisms in major depressive disorder.
    CMAJ. 2009 Feb 3;180(3):305-13 PMID: 19188629
  18. Serotoninergic mechanisms in the treatment of obsessive-compulsive disorder.
    Drug Discov Today. 2008 Apr;13(7-8):325-32 PMID: 18405845
  19. Neuroanatomic observations of the brain in autism: a review and future directions.
    Int J Dev Neurosci. 2005 Apr-May;23(2-3):183-7 PMID: 15749244
  20. The primate serotonergic system: a review of human and animal studies and a report on Macaca fascicularis.
    Adv Neurol. 1986;43:407-68 PMID: 2418648
  21. Serotonin and brain development: role in human developmental diseases.
    Brain Res Bull. 2001 Nov 15;56(5):479-85 PMID: 11750793
  22. Depleting serotonin enhances both cardiovascular and psychological stress reactivity in recovered patients with anxiety disorders.
    J Clin Psychopharmacol. 2006 Aug;26(4):414-8 PMID: 16855462
  23. Apoptotic mechanisms and the synaptic pathology of schizophrenia.
    Schizophr Res. 2006 Jan 1;81(1):47-63 PMID: 16226876
  24. Neuropathology of Alzheimer's disease.
    Mt Sinai J Med. 2010 Jan-Feb;77(1):32-42 PMID: 20101720
  25. Reduced serum levels of brain-derived neurotrophic factor in adult male patients with autism.
    Prog Neuropsychopharmacol Biol Psychiatry. 2006 Dec 30;30(8):1529-31 PMID: 16876305
  26. Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry.
    Neuropsychopharmacology. 2006 Jan;31(1):47-57 PMID: 16012532
  27. Evidence of brain overgrowth in the first year of life in autism.
    JAMA. 2003 Jul 16;290(3):337-44 PMID: 12865374
  28. Serotonin function is associated with behavioral response to a novel conspecific in marmosets.
    Am J Primatol. 2006 Aug;68(8):812-24 PMID: 16847970
  29. Diagnostic validity of sensory over-responsivity: a review of the literature and case reports.
    J Autism Dev Disord. 2008 Mar;38(3):516-29 PMID: 17917804
  30. Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation.
    Ann Neurol. 2001 May;49(5):597-606 PMID: 11357950
  31. Parkinson's disease: a novel MRI method for determining structural changes in the substantia nigra.
    J Neurol Neurosurg Psychiatry. 1999 Dec;67(6):815-8 PMID: 10567508
  32. Sensory processing in adults with autism spectrum disorders.
    Autism. 2009 May;13(3):215-28 PMID: 19369385
  33. Down syndrome children often have brain with maturation delay, retardation of growth, and cortical dysgenesis.
    Am J Med Genet Suppl. 1990;7:274-81 PMID: 2149962
  34. Prenatal cocaine exposure disrupts the development of the serotonergic system.
    Brain Res. 1992 Feb 14;572(1-2):57-63 PMID: 1535274
  35. Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample.
    J Am Acad Child Adolesc Psychiatry. 2008 Aug;47(8):921-9 PMID: 18645422
  36. Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine.
    J Pharmacol Exp Ther. 1987 Jul;242(1):364-71 PMID: 3475452
  37. Ontogeny of brain and blood serotonin levels in 5-HT receptor knockout mice: potential relevance to the neurobiology of autism.
    J Neurochem. 2006 Nov;99(3):1019-31 PMID: 16981893
  38. Ontogeny of the serotonergic projection to rat neocortex: transient expression of a dense innervation to primary sensory areas.
    Proc Natl Acad Sci U S A. 1987 Jun;84(12):4322-6 PMID: 3473503
  39. Pharmacological evaluation of the stress-induced social avoidance model of anxiety.
    Brain Res Bull. 2006 Mar 31;69(2):153-60 PMID: 16533664
  40. The neuropathology of autism: a review.
    J Neuropathol Exp Neurol. 2005 Nov;64(11):925-35 PMID: 16254487
  41. Mechanisms of tau-induced neurodegeneration.
    Acta Neuropathol. 2009 Jul;118(1):53-69 PMID: 19184068
  42. Serotonergic systems, anxiety, and affective disorder: focus on the dorsomedial part of the dorsal raphe nucleus.
    Ann N Y Acad Sci. 2008 Dec;1148:86-94 PMID: 19120094
  43. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism.
    Prog Neurobiol. 2005 Jun;76(2):77-98 PMID: 16081203
  44. The serotoninergic innervation of cerebral cortex: different classes of axon terminals arise from dorsal and median raphe nuclei.
    Synapse. 1987;1(2):153-68 PMID: 2463687
  45. Autism and developmental abnormalities in children with perinatal cocaine exposure.
    J Natl Med Assoc. 1992 Apr;84(4):315-9 PMID: 1380564
  46. Neurotoxicity of MDMA and related compounds: anatomic studies.
    Ann N Y Acad Sci. 1990;600:649-61; discussion 661-4 PMID: 1979216
  47. Regression in pervasive developmental disorders: seizures and epileptiform electroencephalogram correlates.
    Pediatrics. 1997 Apr;99(4):560-6 PMID: 9093299
  48. Auditory discrimination and auditory sensory behaviours in autism spectrum disorders.
    Neuropsychologia. 2009 Nov;47(13):2850-8 PMID: 19545576
  49. Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria.
    Lancet Neurol. 2009 Dec;8(12):1150-7 PMID: 19909913
  50. Cerebral dominance for language function in adults with specific language impairment or autism.
    Brain. 2008 Dec;131(Pt 12):3193-200 PMID: 18953053
  51. Stereological analysis of amygdala neuron number in autism.
    J Neurosci. 2006 Jul 19;26(29):7674-9 PMID: 16855095
  52. Dystrophic serotonergic axons in neurodegenerative diseases.
    Brain Res. 2008 Jun 27;1217:185-94 PMID: 18502405
  53. Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism.
    Arch Gen Psychiatry. 2009 Jun;66(6):583-90 PMID: 19487623
  54. The neuropharmacology of impulsive behaviour.
    Trends Pharmacol Sci. 2008 Apr;29(4):192-9 PMID: 18304658
  55. Serotonin neurons, neuroplasticity, and homeostasis of neural tissue.
    Neuropsychopharmacology. 1999 Aug;21(2 Suppl):33S-45S PMID: 10432487
  56. Further studies in the developmental hyperserotonemia model (DHS) of autism: social, behavioral and peptide changes.
    Brain Res. 2008 Jan 16;1189:203-14 PMID: 18062943
  57. Selective alteration of personality and social behavior by serotonergic intervention.
    Am J Psychiatry. 1998 Mar;155(3):373-9 PMID: 9501748
  58. White matter abnormalities in early-onset schizophrenia: a voxel-based diffusion tensor imaging study.
    J Am Acad Child Adolesc Psychiatry. 2005 Sep;44(9):934-41 PMID: 16113622
  59. Correlation of CSF 5-HIAA concentration with sociality and the timing of emigration in free-ranging primates.
    Am J Psychiatry. 1995 Jun;152(6):907-13 PMID: 7538731
  60. The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6.
    Schizophr Res. 1998 Jun 22;32(1):9-15 PMID: 9690329
  61. Dendritic differentiation in human cerebral cortex: normal and aberrant developmental patterns.
    Adv Neurol. 1975;12:91-134 PMID: 1155280
  62. Modeling early cortical serotonergic deficits in autism.
    Behav Brain Res. 2007 Jan 10;176(1):94-108 PMID: 17034875
  63. Molecular profiles of schizophrenia in the CNS at different stages of illness.
    Brain Res. 2008 Nov 6;1239:235-48 PMID: 18778695
  64. Lewy body pathology in Alzheimer's disease.
    J Mol Neurosci. 2001 Oct;17(2):225-32 PMID: 11816795
  65. Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys.
    Ann Neurol. 1997 Oct;42(4):666-9 PMID: 9382481
  66. Significance of abnormalities in developmental trajectory and asymmetry of cortical serotonin synthesis in autism.
    Int J Dev Neurosci. 2005 Apr-May;23(2-3):171-82 PMID: 15749243
  67. Neurobiology of aggression and violence.
    Am J Psychiatry. 2008 Apr;165(4):429-42 PMID: 18346997
  68. Origin of the blood hyperserotonemia of autism.
    Theor Biol Med Model. 2008 May 22;5:10 PMID: 18498654
  69. Neuroglial activation and neuroinflammation in the brain of patients with autism.
    Ann Neurol. 2005 Jan;57(1):67-81 PMID: 15546155
  70. Serotonin (1A) receptor involvement in acute 3,4-methylenedioxymethamphetamine (MDMA) facilitation of social interaction in the rat.
    Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jun;29(5):648-57 PMID: 15908091
  71. White matter changes in schizophrenia: evidence for myelin-related dysfunction.
    Arch Gen Psychiatry. 2003 May;60(5):443-56 PMID: 12742865
  72. Dendritic atrophy in children with Down's syndrome.
    Ann Neurol. 1986 Oct;20(4):520-6 PMID: 2947535
  73. Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease.
    Ann Neurol. 1990 Apr;27(4):373-85 PMID: 1972319
  74. Hyperserotonemia in adults with autistic disorder.
    J Autism Dev Disord. 2007 Nov;37(10):1934-40 PMID: 17165147
  75. Clomipramine in adults with pervasive developmental disorders: a prospective open-label investigation.
    J Child Adolesc Psychopharmacol. 1997 Summer;7(2):109-21 PMID: 9334896
  76. Developmental disruption of serotonin transporter function impairs cerebral responses to whisker stimulation in mice.
    Proc Natl Acad Sci U S A. 2005 Apr 12;102(15):5582-7 PMID: 15809439
  77. Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study.
    J Neurol Sci. 2005 Dec 15;239(1):11-9 PMID: 16185716
  78. Whole blood serotonin in autistic and normal subjects.
    J Child Psychol Psychiatry. 1987 Nov;28(6):885-900 PMID: 3436995
  79. Regeneration of serotonergic immunoreactive fibers in the brain of 5,6-dihydroxytryptamine treated rat.
    J Hirnforsch. 1994;35(1):159-80 PMID: 8021452
  80. Serotoninergic terminal transporters are differentially affected in Parkinson's disease and progressive supranuclear palsy: an autoradiographic study with [3H]citalopram.
    Neuroscience. 1993 Jun;54(3):691-9 PMID: 8332256
  81. Neuropathology of infantile autism.
    J Neuropathol Exp Neurol. 1998 Jul;57(7):645-52 PMID: 9690668
  82. Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children.
    J Pediatr. 1961 Mar;58:315-20 PMID: 13747230
  83. Apoptotic mechanisms in the pathophysiology of schizophrenia.
    Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jun;29(5):846-58 PMID: 15908096
  84. The neuropathology of phenylketonuria: human and animal studies.
    Eur J Pediatr. 2000 Oct;159 Suppl 2:S102-6 PMID: 11043154
  85. Review of the evidence for treatment of children with autism with selective serotonin reuptake inhibitors.
    J Spec Pediatr Nurs. 2009 Jul;14(3):183-91 PMID: 19614827
  86. Hippocampus in autism: a Golgi analysis.
    Acta Neuropathol. 1996;91(1):117-9 PMID: 8773156
  87. Variation in ITGB3 is associated with whole-blood serotonin level and autism susceptibility.
    Eur J Hum Genet. 2006 Aug;14(8):923-31 PMID: 16724005
  88. Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children.
    Ann Neurol. 1999 Mar;45(3):287-95 PMID: 10072042
  89. Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study.
    Neurology. 2001 Jul 24;57(2):245-54 PMID: 11468308
  90. Low platelet-poor plasma levels of serotonin in adult autistic patients.
    Neuropsychobiology. 2004;50(2):157-60 PMID: 15292671
  91. Effects of ethanol and 5-HT1A agonists on astroglial S100B.
    Brain Res Dev Brain Res. 2002 Dec 15;139(2):97-105 PMID: 12480124
  92. Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease.
    Brain Res. 1983 Sep 26;275(2):321-8 PMID: 6626985
  93. Neuroanatomy of autism.
    Trends Neurosci. 2008 Mar;31(3):137-45 PMID: 18258309
  94. Parkinson's disease.
    Lancet. 2009 Jun 13;373(9680):2055-66 PMID: 19524782
  95. The amygdala is enlarged in children but not adolescents with autism; the hippocampus is enlarged at all ages.
    J Neurosci. 2004 Jul 14;24(28):6392-401 PMID: 15254095
  96. Neuropathological findings in autism.
    Brain. 2004 Dec;127(Pt 12):2572-83 PMID: 15329353
  97. Brain serotonin transporter binding in non-depressed patients with Parkinson's disease.
    Eur J Neurol. 2007 May;14(5):523-8 PMID: 17437611
  98. Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide.
    J Psychiatr Res. 2008 Jan;42(2):151-7 PMID: 17174336
  99. Autism spectrum disorders: concurrent clinical disorders.
    J Child Neurol. 2008 Jan;23(1):6-13 PMID: 18056691
  100. Autism at the beginning: microstructural and growth abnormalities underlying the cognitive and behavioral phenotype of autism.
    Dev Psychopathol. 2005 Summer;17(3):577-97 PMID: 16262983
  101. The enteric nervous system II: gastrointestinal functions.
    Pharmacol Toxicol. 2003 Jun;92(6):249-57 PMID: 12787256
  102. Hyperserotonemia and amine metabolites in autistic and retarded children.
    Arch Gen Psychiatry. 1977 May;34(5):521-31 PMID: 860890
  103. Macrocephaly and the control of brain growth in autistic disorders.
    Prog Neurobiol. 2005 Sep-Oct;77(1-2):38-56 PMID: 16280193
  104. Risk factors for self-injurious behaviours among 222 young children with autistic disorders.
    J Intellect Disabil Res. 2003 Nov;47(Pt 8):622-7 PMID: 14641810
  105. Pyramidal cell abnormalities in the motor cortex of a child with Down's syndrome. A Golgi study.
    J Comp Neurol. 1976 May 1;167(1):63-81 PMID: 131810
  106. Serotonin and epilepsy.
    J Neurochem. 2007 Feb;100(4):857-73 PMID: 17212700
  107. Parkinson's disease: distribution of Lewy bodies and monoamine neuron system.
    Acta Neuropathol. 1976 Apr 26;34(4):311-9 PMID: 179263
Article Info
Journal
Anatomical record (Hoboken, N.J. : 2007)
Abbr.
Anat Rec (Hoboken)
ISSN
1932-8494
Published
2011-10-00
Epub
2011-00-08
Pages
1653-62
Language
English
Region
United States
NLM ID
101292775
PMCID
PMC4112519
Subset
IM
Grants
NIA NIH HHS · P30 AG008051 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com